Authors: Sherer, Y Levy, Y Langevitz, P Rauova, L Fabrizzi, F Shoenfeld, Y

Citation: Y. Sherer et al., Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases, PHARMACOL, 62(3), 2001, pp. 133-137

Authors: Terryberry, JW Shoenfeld, Y Sherer, Y Levy, Y Fabrizzi, F Ahmed, A Peter, JB

Citation: Jw. Terryberry et al., Detection of antibodies to gangliosides and glycolipids in various intravenous immunoglobulin (IVIg) preparations, IMMUNOL INV, 29(3), 2000, pp. 337-347

Authors: Levy, Y Sherer, Y Langevitz, P Lorber, M Rotman, P Fabrizzi, F Shoenfeld, Y

Citation: Y. Levy et al., Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - A preliminary report, CLIN RHEUMA, 19(3), 2000, pp. 207-211

Authors: Sherer, Y Langevitz, P Levy, Y Fabrizzi, F Shoenfeld, Y

Citation: Y. Sherer et al., Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin, LUPUS, 8(4), 1999, pp. 324-327

Authors: Sherer, Y Levy, Y Langevitz, P Lorber, M Fabrizzi, F Shoenfeld, Y

Citation: Y. Sherer et al., Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin, CLIN RHEUMA, 18(2), 1999, pp. 170-173

Authors: Sherer, Y Levy, Y Fabrizzi, F Shoenfeld, Y

Citation: Y. Sherer et al., Immunomodulation of various autoimmune diseases by intravenous immunoglobulin, DRUGS TODAY, 35(7), 1999, pp. 513-518